Search

everythinglearnresearchcommunity

for

Search:↓

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Gene therapy in mice increased lifespan and improved health without causing cancer.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

The sensor accurately measures thallium ions in solutions with high selectivity.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

Baricitinib was effective in treating both early and late onset alopecia areata.

The gel effectively delivers drugs to the eye, fights bacteria, and protects against oxidative stress.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Extracellular vesicles show promise in skin treatments but need more research and standardization.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.